StockGlow

Sarepta Therapeutics, Inc. (AB3A.F)

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases.

13.50+0.02%Healthcare
Compare AB3A.F with
StockGlow Score
6
Bearish
BearishBullish
1 year ago-2.9%

The outlook

Sarepta Therapeutics, Inc. currently reads as bearish based on below its 50- & 200-day averages, 8% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendBelow its 50- & 200-day averages
52-week range8% of the way from its 52-week low to high
Market cap
$1.43B
52-wk high
21.42
52-wk low
12.82
50-day avg
14.80
200-day avg
16.50
Trailing P/E
43.5

Similar stocks

J7Z.FJazz Pharmaceuticals plc$223.30+0.59%UTH.FUnited Therapeutics Corporation$454.80-0.22%38I.FIntellia Therapeutics, Inc.$9.16+0.77%2L9.FVisionWave Holdings, Inc.$1.70-10.55%UP0.FUltragenyx Pharmaceutical Inc.$21.47-4.54%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy